GLP-1 Drugs May Offer Surprising Health Benefits Beyond Weight Loss

New research shows these diabetes medications may help with chronic inflammation, addiction, and more.

Mar. 28, 2026 at 4:25pm

Got story updates? Submit your updates here. ›

Drugs like Ozempic and Wegovy, originally developed to treat type 2 diabetes, are known for helping with weight loss and blood sugar control. But new research indicates these GLP-1 medications may offer a range of additional health benefits, including lowering the risk of cardiovascular disease, improving sleep apnea, and reducing chronic pain and substance abuse issues.

Why it matters

As GLP-1 drugs become more widely prescribed, understanding their full scope of potential benefits is crucial for doctors and patients. These findings could expand the use of these medications beyond just weight loss and diabetes management.

The details

GLP-1 drugs work by slowing digestion, reducing hunger signals in the brain, and helping the body regulate insulin more effectively. In addition to aiding weight loss and blood sugar control, early research suggests they may also reduce chronic inflammation, ease symptoms of conditions like rheumatoid arthritis, and curb addictive behaviors. However, the long-term effects of these medications are still being studied, and doctors caution that stopping GLP-1 drugs often reverses the benefits.

  • The new research on the additional health benefits of GLP-1 drugs was published on March 28, 2026.

The players

Dr. Brian Burtch

An endocrinologist with University Hospitals in Cleveland who has studied the effects of GLP-1 drugs.

Got photos? Submit your photos here. ›

What they’re saying

“There's a lot of other things they do. We know that many of them lower the risk of cardiovascular disease, they have made improvements in sleep apnea, we use them in fatty liver disease, which is the biggest cause of cirrhosis and liver failure.”

— Dr. Brian Burtch, Endocrinologist

“We see that patients with chronic inflammatory issues, rheumatoid arthritis for example, they seem to experience less pain. We've seen some patients who suffer from addictions, substance addictions, have less desire to want to abuse these substances when on these medications.”

— Dr. Brian Burtch, Endocrinologist

What’s next

Doctors recommend that patients considering starting a GLP-1 drug should first consult their physician to address any existing gastrointestinal issues, as these medications can sometimes exacerbate conditions like chronic heartburn or constipation.

The takeaway

While GLP-1 drugs were originally developed to treat type 2 diabetes, this new research suggests they may have a much broader range of potential health benefits. As these medications become more widely prescribed, understanding their full scope of effects will be crucial for doctors and patients.